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Free radicalsMelanoma cell lines and cells corresponding to premalignant melanocytes were established by our group
after subjecting a nontumorigenic murine melanocyte lineage, melan-a, to sequential cycles of anchorage
blockade. Previous results showed that in melan-a cells the superoxide level increases after such procedure.
Superoxide production during melanocyte de-adhesion was inhibited by L-sepiapterin, the precursor of eNOS
cofactor BH4, and increased by the inhibitor of BH4 synthesis, DAHP, hence indicating a partial uncoupling
state of eNOS. The eNOS uncoupling seems to be maintained in cells derived from melan-a, because they
present decreased nitric oxide and increased superoxide levels. The inhibition of superoxide production in
Tm5 melanoma cells with L-sepiapterin reinforces their eNOS-uncoupled state. The maintenance of oxidative
stress seems to be important in melanoma apoptosis resistance because Mn(III)TBAP, a superoxide scavenger,
or L-sepiapterin renders Tm5 cells more sensitive to anoikis and chemotherapy. More importantly, eNOS
uncoupling seems to play a pivotal role in melanocyte malignant transformation induced by sustained
anchorage impediment, because no malignant transformation was observed when L-NAME-treated
melanocytes were subjected to sequential cycles of de-adhesion. Our results show that uncoupled eNOS
contributes to superoxide production during melanocyte anchorage impediment, contributing to anoikis
resistance and malignant transformation.ate; BH4, tetrahydrobiopterin;
ypyrimidine; L-NAME, L-NG-
s; NOS, nitric oxide synthase;
roethidium; Mn(III)TBAP, Mn
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products, and their generation correlates with activation of signaling
pathways controlling biological processes such as cell proliferation,
differentiation, and migration [1,2]. The effects of ROS depend on the
balance between their generation and their detoxiﬁcation by
enzymatic or nonenzymatic systems [3]. Moderate increases in ROS
levels can promote cell proliferation and differentiation, whereas
excessive amounts of ROS can cause oxidative damage to lipids,
proteins, and DNA [4]. Therefore, themaintenance of ROS homeostasis
is crucial for normal cell growth and survival. Several observationshave also suggested the involvement of ROS in malignant transfor-
mation and tumor progression [5,6]. ROS production is increased in
some tumor types, including melanoma, a ﬁnding that has been
associated with mitogenesis, apoptosis resistance, and angiogenesis
[7,8]. Mitochondria are the main source of ROS in nonphagocytic cells,
but other cytosolic enzymatic systems, such NADPH oxidases,
xanthine oxidases, and nitric oxide synthases, can also generate
superoxide [9].
It has been demonstrated that uncoupled nitric oxide synthase
(NOS) can also be a source of superoxide production [10,11]. NOSs are
homodimeric oxidoreductases that catalyze NO production from
L-arginine guanidine nitrogen using molecular oxygen. The NOS
reductase domain shares a close homology with cytochrome P450
enzymes, generating electron ﬂow from NADPH through FAD and
FMN ﬂavins. These are then transferred to the oxidase domain of other
monomers in which L-arginine oxidation occurs at the heme group in
the active site. Multiple integrated pathways, including activation by
calcium–calmodulin, phosphorylation at key serine and threonine
residues, and substrate and cofactor availability, regulate NOS activity
[12]. A critical aspect of NOS function is the requirement of the
cofactor tetrahydrobiopterin (BH4). In its absence NOS dimerization is
destabilized and NOS catalytic activity becomes “uncoupled,”
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formation has a central role in the pathogenesis of vascular diseases
such as diabetes, hypertension, and atherosclerosis [14,15].
At least to our knowledge, there is no information relating NOS
uncoupling and malignant transformation and tumor progression.
Many studies have shown increased expression of inducible (i) NOS in
tumor cells, including melanomas, but no mechanisms have been
described regarding the products generated by this enzyme [16].
Recently, an in vitro murine melanocyte malignant transformation
model was developed in our laboratory, after subjecting a nontumori-
genic melanocyte lineage, melan-a, to sequential cycles of anchorage
impediment [17]. During anchorage blockade, melanocytes present
increased levels of superoxide, nitric oxide, and hydrogen peroxide
[18]. Surprisingly, L-NG-nitroarginine methyl ester (L-NAME), a NOS
inhibitor, abrogated the superoxide increase, but not nitric oxide
levels, in melanocytes maintained in suspension. Additionally, the
endothelial (e) NOS transcript level was also augmented under this
condition. The aim of this study was to identify the sources of
superoxide produced during melanocyte anchorage blockade and the
impact of superoxide in melanocyte malignant transformation.
Experimental procedures
Cell culture
The nontumorigenic melan-a melanocyte lineage [19] was
cultured at 37 °C in humidiﬁed 95% air–5% CO2 in RPMI, pH 6.9,
supplemented with 5% (v/v) fetal bovine serum (Invitrogen, Scotland,
UK), 200 nM phorbol 12-myristate 13-acetate (PMA; Calbiochem,
Darmstadt, Germany), 100 U/ml penicillin, and 100 U/ml streptomy-
cin (Invitrogen, Grand Island, NY, USA). Premalignant melanocyte
lineage 4 C, nonmetastatic melanoma cell line 4C11−, and metastatic
melanoma cell lines 4C11+ and Tm5, established after subjecting
melan-a cells to sequential cycles of anchorage blockade [17], were
cultured as melan-a cells, but in the absence of PMA. For all
experiments, cultures at 70 to 80% conﬂuence were used, because
cellular density inﬂuences ROS production.
De-adhesion cycles in the presence of L-NAME
The nontumorigenic melan-a lineage (105 cells/ml) was plated on
1% agarose-coated plates and cultured for 96 h as described above in
the presence of 1 mM L-NAME (Cayman Chemical, Ann Arbor, MI,
USA). Small spheroids were collected by decantation and plated under
adherent conditions. Cells were allowed to proliferate to subconﬂuent
growth. De-adhesion (spheroid formation) cycles were repeated four
times; after the last de-adhesion step, spheroids were counted and
plated at limiting dilution (0.5–1 spheroid/well) on 96-well plates. At
least ﬁve clones were randomly selected and subjected to tumorige-
nicity assay.
Treatments during anchorage blockade
For anchorage blockade assays, adherent melan-a melanocytes
were harvested by mild trypsin treatment and 1×105 cells/ml were
cultured on 1% (w/v) agarose-coated plates for 3 h (D3h) under the
same conditions described above. Alternatively, melan-a cells were
treated with 4 mM 2,4-diamino-6-hydroxypyrimidine (DAHP),
40 μM L-sepiapterin, 1 mM L-NAME, or 4 μM ebselen (all from
Cayman Chemical) in 0.5% (v/v) FBS-supplemented RPMI for 16 h,
or with 100 μM apocynin (Calbiochem), 50 μM Mn(III) tetrakis
(4-benzoic acid) porphyrin (Mn(III)TBAP; Cayman Chemical), and
500 μM 2-(4-carboxyphenyl)-4,5-dihydro-4,4,5,5-tetramethyl-1H-
imidazolyl-1-oxy-3-oxide (PTIO; Calbiochem) for 2 h in 0.5% (v/v)
FBS-supplemented RPMI, or with 1 μM antimycin (Sigma, Stein-
heim, Germany) and 5 μM rotenone (Sigma) for 3 h in 0.5% FBS-supplemented RPMI. After treatment, the cells were harvested and
placed on agarose-coated plates (1×105 cells/ml) for 3 h (D3h) with
or without the inhibitors or scavengers described above. In parallel,
adherent melan-a melanocytes were maintained for an additional
3 h in the presence of inhibitors or scavengers before being
harvested (D0).
Superoxide measurement
Intracellular superoxide levelsweremeasuredusingdihydroethidium
(DHE; Molecular Probes, Eugene, OR, USA), a nonﬂuorescent cell-
permeative indicator for superoxide, as previously described [20].
Adherent and suspended melan-a cells and melan-a-derived cell lines
were washed and incubated in PBS for 30 min at 37 °C before being
incubated with 200 ng/ml DHE for an additional 30 min at 37 °C in the
dark. After being washed, the cells were analyzed by ﬂow cytometry
(FACSCalibur; Becton–Dickinson, Franklin Lakes, NJ, USA) (excitation
wavelength 480 nm; emission wavelength 567 nm). Alternatively,
superoxide generation was determined by chemiluminescence using
coelenterazine (Calbiochem) as previously described [21]. Brieﬂy, 1×105
cells were seeded in 96-well plates (D0) or subjected to adhesion
impediment for 3 h (D3h). After this period, 2 μM coelenterazine was
added to themediumand chemiluminescencewas assessed immediately
in a luminometer (Softmax Pro; Molecular Devices, Sunnyvale, CA, USA).
Nitric oxide measurement
Extracellular NO levels in adherent (D0) and de-adherent melan-a
cells (D3h), treated or not with the scavengers described above, and in
melan-a-derived cell lines were determined after a gas-phase
chemiluminescence reaction of NO with ozone by a NO analyzer
(NOA 280; Sievers Instruments, Boulder, CO, USA). A standard curve
was established with a set of serial dilutions (0.1–100 μM) of sodium
nitrate. The concentrations of NO metabolites in samples were
determined by comparison with a standard curve and expressed as
micromoles per milligram of protein. Data collection and analysis
were performed using the NOANalysis software (version 3.21; Sievers
Instruments). Alternatively, the intracellular NO levels were mea-
sured using the ﬂuorescence NO indicator diaminoﬂuorescein-2-
diacetate (DAF-2DA; Molecular Probes) in adherent cells (D0),
suspended cells (D3h), and melan-a-derived cell lines. Cells were
incubated with 10 μM DAF-2DA at room temperature for 30 min,
rinsed with PBS, and analyzed by ﬂow cytometry in a FACScan
(Becton–Dickinson) (excitation wavelength 495 nm; emission wave-
length 515 nm).
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
assay
Cell viability in the presence of various concentrations of inhibitors
and scavengers was estimated using a standard MTT assay (Sigma).
Melan-a cells (2×104 cells/ml)were cultured in completemedium for
24 h on 96-well plates. The medium on the cell cultures was replaced
by fresh medium containing 0.5% (v/v) FBS and then the cells were
treated for 16 h with L-sepiapterin (10, 20, 40, 60, 80, and 100 μM),
ebselen (1, 2, and 4 μM), or DAHP (1, 2, 4, 8, 10, and 12 mM), or for 2 h
with PTIO (125, 250, and 500 μM), Mn(III)TBAP (25, 50, and 100 μM),
or apocynin (25, 50, 100, 200, and 400 μM), or for 3 h with rotenone
(5, 10, and 20 μM) or antimycin (0.25, 0.5, and 1 μM) at 37 °C in 5%
CO2. The absorbance at 570 nm was recorded in each well using an
ELISA microplate reader. Melan-a and Tm5 cell viability under
anchorage blockade conditions was also estimated by MTT assay.
For anchorage blockade assays, adherent melan-a and Tm5 cells were
harvested by mild trypsin treatment and 2.5×103 cells were cultured
per milliliter on 1% (w/v) agarose-coated plates for 96 h (D96h) in the
absence or presence of 50 μM Mn(III)TBAP or 20 μM L-sepiapterin in
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and Tm5 cells after treatment for 96 h under the same conditions as
described above was also evaluated.
Trypan blue dye exclusion assay
Cell viability of adherent melan-a and Tm5 cells was evaluated
using the trypan blue dye exclusion assay. Melan-a and Tm5 cells
(2×104 cells) were cultured in complete medium on six-well plates.
After 24 h the mediumwas replaced by freshmedium containing 0.5%
(v/v) FBS and the cells were treated for 16 hwith 20 μML-sepiapterin.
or the medium was replaced by fresh medium without FBS for 2 h
with 50 μM Mn(III)TBAP. Subsequently, both cell lines were treated
for 96 h in complete medium with 20 μM L-sepiapterin or 50 μM Mn
(III)TBAP. Adherent melan-a and Tm5 cells were harvested by mild
trypsin treatment and suspended in 1 ml of completemedium. Trypan
blue 0.4% solution (Molecular Probes) was added to an equal volume
of cell suspension and the cells were counted in a Neubauer chamber.
Clonogenic cell-survival assay
Melan-a and Tm5 cells were cultured in complete medium for 24 h
on six-well plates. The medium on the cell cultures was replaced by
fresh medium containing 0.5% (v/v) FBS and then the cells were
treated for 16 h with 20 μM L-sepiapterin or for 2 h with 50 μM Mn
(III)TBAP. Adherent melan-a and Tm5 cells were harvested by mild
trypsin treatment and 2.5×103 cells/ml were cultured on 1% (w/v)
agarose-coated plates for 96 h (D96h) in the absence or presence of
50 μM Mn(III)TBAP or 20 μM L-sepiapterin in fresh medium contain-
ing 5% (v/v) FBS at 37 °C in 5% CO2. Melan-a and Tm5 cells were
collected by centrifugation, seeded on 60-mm dishes and grown for
3 days, for Tm5 cells, or 5 days, for melan-a cells, to allow colony
formation. Colonies were washed with PBS, ﬁxed in 3.7% (v/v)
formaldehyde for 15 min, stained with 1% toluidine blue for 5 min,
and washed with water. For quantiﬁcation of surviving cells, the
staining was dissolved in 1% SDS and the absorbance at 570 nm was
evaluated using an ELISA microplate reader.
In vitro cytotoxic effects of carboplatin
Tm5 cells (2×105) were seeded in 96-well plates in culture
medium supplemented with 5% (v/v) FBS. After being seeded, the
Tm5 cells were incubated in the presence or absence of 50 μMMn(III)
TBAP in fresh medium containing 0.5% (v/v) FBS. After 16 h, the
medium was replaced by fresh medium with 100 μM carboplatin in
the presence or absence of 50 μM Mn(III)TBAP and the cells were
incubated for an additional 48 h. The cytotoxic effect of carboplatin
was evaluated using the MTT assay or trypan blue dye exclusion assay
as described. The absorbance at 570 nm was recorded in each well
using an ELISA microplate reader.
Tumorigenicity assays
The sequential anchorage blockade protocol resulting in melano-
cyte malignant transformation was performed by subjecting adherent
melan-a cells pretreated with 1 mM L-NAME for 16 h to sequential
cycles of substrate adhesion impediment in the presence of 1 mM
L-NAME. Cells from subconﬂuent monolayers were harvested after
trypsin treatment, counted, and then suspended in PBS. The clones
derived from sequential cycles of anchorage blockade in the presence
of L-NAME (2×106 cells) and a positive control (4C11+, melanoma
cell line derived from repetitive cycles of melan-a anchorage
blockade) were injected subcutaneously into the ﬂanks of 6- to 8-
week-old C57BL/6 syngeneic female mice. Animals were kept under
12-h daylight cycles, without food restriction, and checked daily for
tumor development. The tumor volume (mm3) was measured usingthe formula d2×D/2, where d represents the minimum diameter and
D the maximum diameter. Each experimental group consisted of at
least four animals.Statistical analysis
Unpaired nonparametric Student's t test was used to analyze
differences between the means using GraphPad Prism version 4 for
Windows (GraphPad, San Diego, CA, USA). The signiﬁcance level was
established at pb0.05.Results
Melanocytes produce increased levels of superoxide and NO when
maintained in suspension
Previous data from our lab showed that the sustained stress
conditions characterized by augmented generation of NO, superoxide,
H2O2, and peroxynitrite may have an important impact on epigenetic
alterations observed along melanocyte malignant transformation
associated with anchorage blockade [18]. Although adherent melano-
cytes produce detectable levels of both NO and superoxide, a signiﬁcant
increase in both of them is observed when these melanocytes are
subjected to anchorage impediment for 3 h (Supplemental Fig. S1). The
speciﬁcity of superoxide measurement by chemiluminescence using
coelenterazine (Supplemental Figs. S1A and B) and by DHE staining
(Supplemental Fig. S1C) and NO measurement by NO analyzer
(Supplemental Fig. S1D) was conﬁrmed by treating cells with the SOD
mimetic Mn(III)TBAP and the NO scavenger PTIO.eNOS is an important source of superoxide produced during melanocyte
anchorage blockade
In all experiments the adherent cells were treated with various
noncytotoxic concentrations of scavengers or inhibitors. To determine
these concentrations, MTT assays were performed with the scaven-
gers PTIO and Mn(III)TBAP (Supplemental Figs. S2A and B, respec-
tively) and inhibitors (Supplemental Fig. S2C-I). Our previous data
showing that treatment with the NOS inhibitor L-NAME impaired
both the increase in DNMT protein levels and the global DNA
hypermethylation observed during melanocyte anchorage blockade
apparently indicated that NO had an important role in these
epigenetic alterations [18]. However, superoxide, but not NO [18],
production was inhibited in suspended melanocytes by L-NAME
treatment. In fact, L-NAME itself can be a source of nonenzymatically
produced NO [23,24]. Alternatively, L-NAME can impair the transfer of
electrons to molecular oxygen, inhibiting superoxide production [11].
In this context, our results might be related to the involvement of NOS
in the generation of superoxide by melanocytes maintained in
suspension. Consistent with this, increased eNOS, but neither iNOS
nor neuronal (n) NOS, expression was observed when melanocytes
were maintained in suspension compared to adherent conditions
([18] and data not shown).
The fact that L-NAMEaddition resulted in a reduction (Figs. 1AandB),
and not in the complete abolishment, of superoxide production suggests
possible additional sources of superoxide in melanocyte anchorage
impediment. To determine whether NADPH oxidases and mitochondria
are those possible sources, melanocytes were treated with the NADPH
oxidase inhibitor apocynin and the mitochondria inhibitors antimycin
and rotenone. No statistically signiﬁcant alteration was observed in
superoxide production during melanocyte anchorage impediment in
the presence of apocynin (Figs. 1C and D), antimycin, or rotenone
(Figs. 1E and F).
Fig. 1. eNOS is involved in superoxide production during melanocyte adhesion impediment. Melan-a cells were incubated or not (NT) with various inhibitors for 16 h; subjected or
not (D0) to anchorage blockade for 3 h (D3h) in the presence of (A and B) 1 mM L-NAME, (C and D) 100 μMapocynin, or (E and F) 1 μMantimycin (ANT) and 10 μM rotenone (ROT);
and analyzed for intracellular superoxide levels by ﬂow cytometry, using dihydroethidium (DHE) (A, C, and E) or chemiluminescence using coelenterazine (B, D, and F). *pb0.05,
***pb0.0001.
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Several data have shown that abnormal regulation of eNOS can
result in the production of superoxide when this enzyme becomes
uncoupled [11,12]. One of the mechanisms underlying the uncoupled
state of eNOS is a deﬁciency of the cofactor BH4 [24]. Melan-a cells
subjected to anchorage blockade in the presence of the BH4 precursor
L-sepiapterin presented decreased levels of superoxide (Figs. 2A and B).
In addition, these cells presented augmented levels of superoxide after
treatment with DAHP, a speciﬁc inhibitor of GTP cyclohydrolase I, the
rate-limiting enzyme in BH4 synthesis (Figs. 2C and D). These data
strongly suggest that eNOS becomes uncoupled in suspended melan-a
cells, leading to generation of increased levels of superoxide. BH4 is
susceptible to oxidation by peroxynitrite, forming dihydrobiopterin
(BH2) and ultimately biopterin [25]. The treatment with DAHP
decreases the NO levels in melanocytes subjected to adhesion
impediment (Fig. 2F), showing the role of BH4 inmaintaining NO levels.
To analyze the possible involvement of peroxynitrite in eNOS
uncoupling,melanocyteswere treatedwith the peroxynitrite scavenger
ebselen. The production of superoxide was reduced during anchorage
blockade after melanocytes were treated with ebselen, suggesting that
the presence of peroxynitrite could favor an eNOS uncoupling state
(Fig. 2E).Abrogating superoxide anion levels results in decreased melanocyte
survival in suspension
The superoxide anion generated in the ﬁrst hours of melan-a cell
de-adhesion is maintained for at least 96 h in suspension (data not
shown). The sustained oxidative stress seems to participate in melan-
a cell survival in suspension as determined by MTT (Figs. 3B and E)
and clonogenicity assay (Fig. 3C). In the presence of superoxide
scavenger, Mn(III)TBAP (Figs. 3B and C), or the BH4 precursor
L-sepiapterin (Fig. 3E), the survival of melan-a cells subjected to
anchorage impediment for 96 h was decreased. It is important to note
that in adherent melan-a cells neither Mn(III)TBAP nor L-sepiapterin
was toxic (Figs. 3A and D).
Melanoma lineages derived from melanocytes subjected to sustained
stress also produce elevated levels of superoxide due to eNOS uncoupling
The intracellular levels of superoxide in melan-a-derived cell lines
representing melanoma progression were analyzed using DHE
staining. The result shows that both premalignant melanocytes (4C
lineage) and melanoma lineages (4C11−, 4C11+, and Tm5 lineages)
generate elevated levels of superoxide (Fig. 4A) and decreased levels
of NO (Figs. 4B and C) compared to the parental lineage, melan-a. To
Fig. 2. Evidence of eNOS uncoupling in melanocytes subjected to anchorage blockade. Melan-a melanocytes were treated or not (NT) for 16 h with (A and B) 40 μM L-sepiapterin, a
precursor of the eNOS cofactor tetrahydrobiopterin (BH4), or (C, D, and F) 4 mMDAHP, a speciﬁc inhibitor of GTP cyclohydrolase I, the rate-limiting enzyme in the synthesis of BH4, or
(E) 4 mM ebselen, a peroxynitrite scavenger, and subjected or not (D0) to anchorage blockade in the presence of inhibitors for 3 h (D3h) and analyzed by ﬂow cytometry for
intracellular superoxide production, using DHE (A and C) or by chemiluminescence using coelenterazine (B, D, and E). (F) The NO production was evaluated by ﬂow cytometry using
DAF in melanocytes treated for 16 h with 4 mM DAHP and subjected to anchorage impediment for 3 h (D3h). *pb0.05, **pb0.005, ***pb0.0001.
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reduction in NO levels in melanoma lineages was due to eNOS
uncoupling, Tm5melanoma cells were treated with the BH4 precursor
L-sepiapterin. The data show signiﬁcant reduction in superoxide
generation (Fig. 4D) and increase in NO levels (Fig. 4E) by melanoma
cells in the presence of L-sepiapterin. Taken together, these results
indicate that eNOS uncoupling is maintained along melanocyte
malignant transformation, resulting in elevated levels of superoxide
throughout neoplastic progression.Abrogating superoxide levels results in decreased melanoma cell survival
in suspension
Sustained oxidative stress seems to be important to the survival of
suspended Tm5melanoma cells as determined byMTT (Figs. 5B and E)
and clonogenicity assays (Figs. 5C and F). We evaluated anoikis
resistance in Tm5 melanoma cells treated or not with either the
superoxide scavenger Mn(III)TBAP (Figs. 5B and C) or L-sepiapterin
(Figs. 5E and F). Decreased superoxide levels rendered Tm5 melanoma
cells more susceptible to anoikis when these cells were maintained in
suspension for 96 h. Is important to note that neither Mn(III)TBAP(Fig. 5A) nor L-sepiapterin (Fig. 5D) was toxic to adherent Tm5
melanoma cells.
Decreased superoxide levels render Tm5 melanoma cells more sensitive
to chemotherapy
One of the main characteristics of melanoma cells is their intrinsic
chemo- and radioresistance. As we observed that superoxide has an
important role in anoikis resistance, we next evaluated if increased
superoxide levels also contribute to the drug-resistant phenotype of
melanoma cells. Fig. 6 shows that treatment with superoxide
scavenger, Mn(III)TBAP, overcomes this resistance mechanism and
renders Tm5 melanoma cells more sensitive to cell death induced by
carboplatin treatment as shown by both MTT (Fig. 6A) and trypan
blue dye exclusion assays (Fig. 6B).
eNOS inhibition during de-adhesion cycles impairs melanocyte
malignant transformation
To establish the importance of superoxide produced by eNOS
uncoupling in melanocyte malignant transformation, the repeated
Fig. 3. Inhibition of superoxide levels renders melanocytes less resistant to survival in suspension. Adherent melan-amelanocytes were cultured in the presence of (A) 50 μMMn(III)
TBAP or (D) 20 μM L-sepiapterin for 96 h and viable cells were evaluated using trypan blue dye exclusion assay. Melan-a melanocytes were treated or not (NT) for (B and C) 2 h with
50 μM Mn(III)TBAP or (E) 16 h with 20 μM L-sepiapterin and subjected to anchorage blockade in the presence of inhibitors for 96 h (D96h), and surviving cells were estimated by
MTT (B and E) or by clonogenicity assay (C). *pb0.05, **pb0.005.
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NOS inhibitor L-NAME. As observed in Fig. 7, the treatment of melan-a
cells with L-NAME before and during each de-adhesion cycle impaired
the acquisition of a malignant phenotype as evaluated by the ability of
cells to form tumors in vivo, reinforcing the fundamental role of eNOS
uncoupling in this process.
Discussion
Our group has recently established a melanocyte malignant
transformation model in which several melanoma lineages were
obtained after subjecting immortalized, but nontumorigenic, mela-
nocytes lineage (melan-a) to serial cycles of anchorage blockade
followed by reattachment under normal culture conditions [17]. We
have further demonstrated increased nitric oxide, superoxide anion,
and hydrogen peroxide intracellular levels in the ﬁrst hours of
melanocyte adhesion impediment [18]. In addition, strong evidence
was found for the involvement of superoxide anion, but not H2O2,
generation in the epigenetic alterations observed during melanocyte
anchorage blockade, because L-NAME, a NOS inhibitor, and N-
acetylcysteine (NAC), an antioxidant, but not catalase or peroxidase,
H2O2 inhibitors, abrogated the increase both in DNMT1 and DNMT3b
expression and in global DNA methylation levels observed under this
condition [18]. In addition to acting like an antioxidant, NAC increases
the expression of MnSOD, decreasing the superoxide anion levels in
lung tissue [26]. However, we cannot exclude the participation ofother reactive oxygen species in the melanocyte malignant transfor-
mation and melanoma progression in our model. It is important to
note that L-NAME treatment leads to decreased superoxide but not
NO levels during de-adhesion. This phenomenon is in agreement with
the literature, considering that the inability of L-NAME to inhibit NO
synthesis in melanoma cells and in other cell types has already been
demonstrated [22,23]. Nevertheless, L-NAME can impair the transfer
of electrons to oxygen, inhibiting the superoxide anion generation by
NOS [11]. Although in vitro biochemical studies demonstrated that
NOS can independently produce superoxide by an enzymatic
uncoupled state under certain pathological conditions [13], NOS
uncoupling in cancer has not been described yet. The treatment of
melan-amelanocytes with the superoxide scavengerMn(III)TBAP and
nitric oxide scavenger PTIO conﬁrmed superoxide (Supplemental Figs.
S1A, B, and C) and NO production (Supplemental Fig. S1D) during
melan-a anchorage blockade.
The involvement of NADPH oxidases in malignant transformation
and tumor progression has been reported by several prior studies
[27,28]. Oncogenic Ras-transfected NIH-3 T3 ﬁbroblasts have en-
hanced superoxide anion production by Nox1 and these ROS levels are
functionally required for Ras transformation [29]. It was further
demonstrated that Nox1-generated ROS mediate oncogenic Ras-
induced up-regulation of VEGF and angiogenesis [30]. Previous work
demonstrated the up-regulation of Nox4 expression inmelanoma [31]
and a recent study suggests the role of Nox4-generated ROS in
melanocyte malignant transformation by regulating the growth of
Fig. 4. The uncoupled eNOS seems to be maintained in melanoma cells derived frommelan-a melanocytes subjected to sustained stress. (A) Intracellular superoxide levels in melan-
a-derived cell lines were analyzed by ﬂow cytometry using DHE and NO levels by (B) ﬂow cytometry using DAF or by (C) NO analyzer. Tm5melanoma cells were treated or not (NT)
with 40 μM L-sepiapterin for 16 h and analyzed by ﬂow cytometry for (D) intracellular superoxide levels using DHE or (E) intracellular NO levels using DAF. ma, melan-a
melanocytes; 4 C, melan-a melanocytes subjected to four de-adhesion cycles; 4C11−, nonmetastatic melanoma lineage; 4C11+ and Tm5, metastatic melanoma lineages. *pb0.05,
**pb0.005, ***pb0.0001.
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superoxide levels during melan-a melanocyte anchorage blockade
(Figs. 1C and D). Apocynin was ﬁrst reported to inhibit ROS
production by activated neutrophils and has been used as an
NADPH inhibitor in various cell types by many investigators [33,34].
However, to act like an NADPH oxidase inhibitor apocynin must be
ﬁrst metabolized by peroxidase to generate apocynin dimers, which
then inhibit the translocation of the p47phox cytoplasmic subunit to
the membrane assembly into active enzyme complex [35]. It has also
been suggested that Nox4 activation does not require the transloca-
tion of p47phox to the membrane [36]. So, in fact, we cannot exclude
NADPH oxidase as an additional source of superoxide in de-adhered
melan-a melanocytes. The expression of NADPH oxidase isoforms in
these cells is under investigation in our laboratory. Additional assays
will be performed to analyze the NADPH oxidase activity in melan-a
cells subjected to de-adhesion.
The main source of superoxide in the nonphagocytic cells is the
mitochondrion. Although we have observed a loss of mitochondrial
membrane potential during melanocyte de-adhesion (data not
shown), the treatment with inhibitors of mitochondrial complexes I
and III, respectively rotenone and antimycin, did not abrogatesigniﬁcantly the superoxide production by melan-a melanocytes
subjected to anchorage blockade (Figs. 1E and F). These data indicate
that themitochondrion is not a source of superoxide anion production
in melan-a cells maintained in suspension.
Uncoupled NOS can also be a source of superoxide under
pathological conditions. Increasing evidence supports that uncoupled
eNOS has a central role in endothelial dysfunction in vascular disease
states [13]. Furthermore, impaired NO-mediated endothelial function
with increased ROS generation is an independent risk factor for
cardiovascular disease [37]. A critical aspect of NOS function is the BH4
availability [24]. Maintenance and stabilization of NOS dimers are
dependent on the presence of BH4, because eNOS dimerization is
essential for NO production. Other than that, BH4 plays a crucial role in
the multistep oxidation of arginine through the N-hydroxy-L-arginine
intermediate and the subsequent generation of NO. Demonstration of
eNOS uncoupling came from studies showing that BH4 availability is
essential to maintaining the electron transfer from NOS ﬂavins
coupled to L-arginine oxidation leading to NO generation. In the
presence of suboptimal concentrations of BH4, eNOS catalytic activity
becomes uncoupled, leading to superoxide production and decreased
NO production. Superoxide release was inhibited by the presence of
Fig. 5. Decreasing superoxide levels increase the susceptibility of melanoma cells to anoikis. Adherent Tm5 melanoma cells were treated or not for 96 h with (A) 50 μMMn(III)TBAP
or (B) 20 μM L-sepiapterin and viable cells were evaluated by trypan blue dye exclusion assay. Tm5 melanoma cells were subjected to anchorage blockade for 96 h (D96h) in the
absence (NT) or presence of (B and C) 50 μMMn(III)TBAP or (E and F) 20 μM L-sepiapterin and surviving cells were estimated by MTT (B and E) and clonogenicity assays (C and F).
*pb0.05, **pb0.005, ***pb0.0001.
1270 F.H.M. Melo et al. / Free Radical Biology & Medicine 50 (2011) 1263–1273BH4 in various systems by pharmacological supplementation or
genetic manipulations [38]. In agreement with this, treatment of
melan-a cells subjected to anchorage blockade with L-sepiapterin, the
BH4 precursor, decreased superoxide anion levels (Figs. 2A and B).
Various studies have revealed that pharmacological BH4 supplemen-
tation improves endothelial function in those who smoke, diabetic or
hypertensive subjects, patients with hypercholesterolemia, and those
with coronary disease [39,40,41]. The cofactor BH4 can be easily
oxidized to form BH2 and biopterin, both incapable of NO catalysis
[37]. Peroxynitrite formed by NO/superoxide reaction could oxidize
BH4 as previously described and thereby promote eNOS uncoupling
[42]. Our previous results have shown increased levels of malondial-
dehyde, one of the major aldehyde products of lipid peroxidation
caused by peroxynitrite action, during melanocyte anchorage block-
ade [18]. In the presence of ebselen, a peroxynitrite scavenger, the
superoxide level decreased signiﬁcantly during melanocyte de-
adhesion (Fig. 2E), suggesting that peroxynitrite stimulates superox-ide production, probably by causing eNOS uncoupling by oxidizing
BH4 cofactor. In addition, it was recently shown that the striking linear
relationship between eNOS protein and cellular BH4 stoichiometry
together with the intracellular BH4:BH2 ratio, rather than absolute
concentrations of BH4, is a key determinant of eNOS uncoupling, even
in the absence of pathological disease [38,43]. Various kinds of stimuli
can modulate NOS expression, including stress signals. Melan-a cells
subjected to anchorage blockade present increased expression of
eNOS [18], but not of nNOS or iNOS (data not shown). This
augmentation of eNOS expression might contribute to disrupting
the balance of the eNOS and BH4 ratio, leading to partial eNOS
uncoupling during de-adhesion, generation of superoxide, and a
biochemical vicious cycle, in which BH4 is oxidized, increasing eNOS
uncoupling and consequently augmenting superoxide and reducing
NO production in melan-a-derived cell lines. Our results showed that
treatment of melan-a cells subjected to anchorage blockade with
DAHP, an inhibitor of GTP cyclohydrolase I, the rate-limiting enzyme
Fig. 6. Decreasing superoxide levels render Tm5 melanoma cells more sensitive to
carboplatin chemotherapy. Tm5 cells were incubated in the presence (Mn) or absence
(NT) of 50 μM Mn(III)TBAP in fresh medium without FBS. After 16 h, the medium was
replaced by fresh complete medium with 100 μM carboplatin in the presence (Cb+
Mn) or absence (Cb) of 50 μM Mn(III)TBAP. After 48 h, viable cells were estimated by
(A) MTT and (B) trypan blue dye exclusion assays. *pb0.05, **pb0.005, ***pb0.0001.
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decreased nitric oxide levels (Fig. 2F). Bendall and colleagues [43]
showed that superoxide production increases in endothelial cells
transfected with the eNOS transgene, but the overexpression of
GTPCHI restored the basal superoxide levels to the wild-type cell
levels, indicating the role of BH4 in NOS coupling. Taken together, our
data suggest the involvement of uncoupled eNOS in the generation of
superoxide in melan-a cells subjected to anchorage blockade. It is
important to note that eNOS uncoupling seems to be partial, because
NO is also produced during melan-a melanocyte de-adhesion
(Supplemental Fig. S1D).Fig. 7. Decreasing superoxide levels impair melanocyte malignant transformation
induced by sustained stress conditions. Melan-a melanocytes treated with L-NAME
were subjected to sequential cycles of adhesion blockade. Cell clones (C3 LN, C4 LN, C5
LN, C6 LN) established after limiting dilution were subcutaneously injected into the
ﬂanks of syngeneic C57BL/6 female mice and tumor development was checked daily.
One clone (4C11+ melanoma cells), obtained after subjecting melan-a melanocytes to
sequential cycles of anchorage blockade in the absence of L-NAME treatment, was also
injected into mice.To our knowledge, at least, the only study suggesting the
involvement of superoxide generation by uncoupled eNOS in cancer
is that from Czesnikiewicz-Guzik and colleagues [34]. In that study,
the authors showed that increased levels of superoxide in oral
squamous cell carcinoma were inhibited by apocynin and L-NAME,
identifying NADPH oxidase and NOS as sources of superoxide
production [34]. On the other hand, the role of iNOS and NO
generation in melanoma progression is well established. Previous
report has shown increased expression of iNOS in melanoma and gain
of antiapoptotic function after constitutive production of endogenous
NO by iNOS, promoting survival of melanoma human cells [44,45].
One of the hallmarks of cell transformation is the acquisition of
anchorage-independent growth and anoikis resistance [46]. Previous
studies demonstrated the role of superoxide in apoptosis resistance.
Inhibition of superoxide production by various inhibitors, superoxide
scavengers, or MnSOD transfection can sensitize tumorigenic cells to
radiation, glucocorticoids, and chemotherapy-induced apoptosis [47,48].
In addition, there is evidence that MnSOD is a tumor suppressor gene in
many cell types, because its expression suppresses the malignant
phenotype of human breast, pancreatic, prostate, and melanoma cancer
cells [49,50]. The survival of melan-a cells subjected to adhesion
impediment for 96 h was evaluated in the presence of the superoxide
scavenger Mn(III)TBAP. We observed that themaintenance of oxidative
stress is associated with anoikis resistance because fewer cells survive if
superoxide is sequestered by Mn(III)TBAP (Figs. 3B and C). In addition,
melan-a melanocyte survival under anchorage-independent conditions
was slightly, but signiﬁcantly (pb0.05), decreased in the presence of the
BH4 precursor L-sepiapterin (Fig. 3E), showing the role of superoxide
from eNOS in melan-a cell anoikis resistance. We can speculate that the
sustained condition of superoxide generation byuncoupled eNOSduring
repetitive cycles of melan-a melanocyte anchorage impediment may
contribute to the acquisition of an anoikis-resistant phenotype. The
superoxide anion inhibition did not decrease the viability of adherent
melan-a cells (Figs. 3A andD), showing the role of superoxide in survival
of cells subjected to stress conditions such as the absence of cell–matrix
interactions. We have shown that cell–matrix interactions are funda-
mental for maintaining the melanocyte normal phenotype, because
sequential de-adhesion cycles lead to neoplastic transformation [17].
The uncoupled eNOS seems to be maintained along melan-a
melanocyte malignant transformation, as we observed high levels of
superoxide (Fig. 4A) and decreased levels of NO (Figs. 4B and C) in
premalignant (4C cell line) and melanoma cells (4C11−, 4C11+, and
Tm5 cell lines). The treatment of Tm5 melanoma cells with BH4
precursor, L-sepiapterin, diminished the superoxide levels (Fig. 4D)
and augmented the NO levels (Fig. 4E), reinforcing the participation of
eNOS in the elevated superoxide production and indicating one more
time the uncoupled state of this enzyme alongmelanoma progression.
The treatment with L-sepiapterin led to a decrease in superoxide
anion level and a less important increase in NO level. This condition
was also observed in other cellular systems [27,43] and may be
explained by the general antioxidant properties of BH4 other than its
function as a NOS cofactor.
Tm5 melanoma cells are more resistant to anoikis than melan-a
melanocytes [51] and abrogation of superoxide production also renders
Tm5 cells more sensitive to anoikis. Treatment with Mn(III)TBAP
(Figs. 5B and C) or L-sepiapterin (Figs. 5E and F) decreased Tm5
melanoma cell survival in de-adherent conditions as demonstrated by
MTT (Figs. 5B and E) or clonogenicity assay (Figs. 5C and F). Adherent
Tm5melanoma cell viability did not decrease afterMn(III)TBAP (Fig. 5A)
or L-sepiapterin treatment (Fig. 5D). Todevelopmetastases, tumorigenic
cells must detach from primary tumor and survive without cell and
matrix interactions. Our results show the involvement of superoxide in
one of the hallmarks of tumor progression, anoikis resistance. Tm5
melanoma cells were treated with the chemotherapeutic carboplatin in
the presence or absence of superoxide anion scavenger, Mn(III)TBAP.
Our data showed that carboplatin ismore toxic to Tm5melanomacells in
1272 F.H.M. Melo et al. / Free Radical Biology & Medicine 50 (2011) 1263–1273the presence of superoxide as evaluated by MTT (Fig. 6A) and trypan
blue dye exclusion assays (Fig. 6B). So, the maintenance of oxidative
stress seems to be important not only in malignant transformation, but
also for abilities acquired during tumor progression such as the
metastatic process and drug resistance. Our result is in accordance
with Pervaiz and colleagues [47], who showed that a pro-oxidant
environment provides resistance to drug-induced cell death in melano-
ma cells. They demonstrated that regulation of tumor cell sensitivity to
apoptotic signals by superoxide may involve the activation of caspase
signaling pathway. The targets of superoxide anion in our model are
under investigation, but we observed the involvement of the Ras–Erk
pathway in superoxide generation (unpublished results).
Finally, we showed the importance of superoxide generation by
uncoupled eNOS in melanocyte malignant transformation induced by
sustained anchorage impediment. Melan-a melanocytes subjected to
sequential cycles of anchorage blockade in the presence of L-NAME,
an exogenous NOS inhibitor, do not acquire a malignant phenotype
(Fig. 7). Because L-NAME treatment abrogated the superoxide
generation during melanocyte anchorage blockade [25], we may
suggest that superoxide has a key role in melanocyte malignant
transformation. Melan-a cells subjected to anchorage blockade
presented altered global DNA methylation levels [18]. The global
DNA hypermethylation observed in these cells is inhibited by L-NAME,
indicating the importance of superoxide in epigenetic alterations
[18]. Themalignant transformation is a result of growth deregulation
due to genetic and epigenetic alterations. Our hypothesis is that the
sustained stress caused by anchorage blockade leads to an epigenetic
reprogramming, altering the expression of key genes involved in
malignant transformation. Therefore, L-NAME could be abrogating
epigenetic reprogramming that is triggered by increased superoxide
levels and consequently the melanocyte malignant transformation.
In accordance with this, data from our laboratory showed that
increased DNMT expression and global DNA hypermethylation
observed in melan-a melanocytes subjected to anchorage impedi-
ment were inhibited by the superoxide scavenger Mn(III)TBAP
(unpublished results).
In conclusion, we have demonstrated in this study that superoxide
generation by eNOS uncoupling contributes to melanocyte malignant
transformation, mediated probably by the loss of BH4 availability.
These mechanisms are potential key targets for therapeutic interven-
tions in melanoma disease. Further studies should consider the
effectiveness of BH4 treatment in melanoma.
Supplementarymaterials related to this article can be found online
at doi: 10.1016/j.freeradbiomed.2011.02.022.
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